Part of the highly regarded Diagnostic Pathology series, this updated volume is a visually stunning, easy-to-use reference covering all aspects of common and rare renal diseases and their variants. Outstanding images-including gross and microscopic pathology, a wide range of stains, and detailed medical illustrations-make this an invaluable diagnostic aid for every practicing pathologist, resident, or fellow. Written by leading pathologists, this second edition presents an up-to-date, concise presentation of major pathological, clinical, pathophysiological, and genetic information for over 240 diagnoses. High-quality, carefully annotated images highlight critical information, including difficult issues of grading and staging and diagnostic dilemmas not covered in depth in other texts Time-saving reference features include bulleted text, a variety of test data tables, key facts in each chapter, annotated images, and an extensive index Thoroughly updated content throughout with a particular emphasis on practical information that directly assists in making and supporting a diagnosis Over 25 new chapters with information on major advances in nephropathology/nephrology that have occurred since the first edition, especially in the classification of MPGN/complement-related diseases, lupus nephritis, transplant pathology, and newly recognized immunologic and genetic diseases such as ciliopathies, tubulointerstitial nephritis, and glomerulopathies Expert Consult eBook version included with purchase allows you to search all of the text, figures, and references from the book on a variety of devices

Author Biography

Anthony C. Chang MD, MBA, MPH, MS After his cardiology training at the Children's Hospital of Philadelphia with his research interest in mathematics and chaos theory in biomedicine, Dr. Anthony Chang was an attending cardiologist in the cardiovascular intensive care unit of Boston Children's Hospital and an assistant professor at Harvard Medical School. Throughout his career as a pediatric cardiac intensive care physician, he has been interested in applications of biomedical data to decision-making. He completed his Masters of Science (MS) in Data Science with a sub-specialization in artificial intelligence from Stanford School of Medicine. He is also a computer scientist-in-residence at Chapman University. He is currently the Chief Intelligence and Innovation Officer and Medical Director of the Heart Failure Program at Children's Hospital of Orange County. He is the founder and medical director of the Medical Intelligence and Innovation Institute (MI3) that is supported by the Sharon Disney Lund Foundation. The institute, founded in 2015, is dedicated to the introduction and implementation of artificial intelligence in medicine and was the first institute of its kind in a hospital. He intends to build a clinician-computer scientist interface with a nascent society (the Medical Intelligence Society) and is the editor-in-chief of Intelligence-based Medicine, the accompanying journal for his book, Intelligence-Based Medicine: Artificial Intelligence and Human Cognition in Clinical Medicine and Healthcare. He is the organizing chair for Artificial Intelligence in Medicine (AIMed) meetings around the world, the largest and most comprehensive clinician-led meetings that focus on applications of artificial intelligence in medicine and the dean of the nascent American Board of Artificial Intelligence in Medicine (ABAIM). He is also the founding president of the Medical Intelligence Society (MIS).